{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T09:01:56Z","timestamp":1792227716512,"version":"4.4.0"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,4,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>STUDY QUESTION<\/jats:title>\n                    <jats:p>Can cytochrome P450 oxidoreductase deficiency (PORD) be revealed in adult women with menstrual disorders and\/or infertility?<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>SUMMARY ANSWER<\/jats:title>\n                    <jats:p>PORD was biologically and genetically confirmed in five adult women with chronically elevated serum progesterone (P) who were referred for oligo-\/amenorrhea and\/or infertility.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>WHAT IS KNOWN ALREADY<\/jats:title>\n                    <jats:p>PORD is an autosomal recessive disease typically diagnosed in neonates and children with ambiguous genitalia and\/or skeletal abnormalities. It is responsible for the decreased activity of several P450 enzymes, including CYP21A2, CYP17A1 and CYP19A1, that are involved in adrenal and\/or gonadal steroidogenesis. Little is known about the optimal way to investigate and treat patients with adult-onset PORD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>STUDY DESIGN, SIZE, DURATION<\/jats:title>\n                    <jats:p>In this series, we report five adult females who were evaluated in three tertiary endocrine reproductive departments between March 2015 and September 2018.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PARTICIPANTS\/MATERIALS, SETTING, METHODS<\/jats:title>\n                    <jats:p>Five women aged 19\u201338\u00a0years were referred for unexplained oligo-\/amenorrhea and\/or infertility. Genetic testing excluded 21-hydroxylase deficiency (21OH-D), initially suspected due to the increased 17-hydroxyprogesterone (17-OHP) levels. Extensive phenotyping, steroid profiling by mass spectrometry, pelvic imaging and next-generation sequencing of 84 genes involved in gonadal and adrenal disorders were performed in all patients. IVF followed by frozen embryo transfer (ET) under glucocorticoid suppression therapy was performed for two patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>MAIN RESULTS AND THE ROLE OF CHANCE<\/jats:title>\n                    <jats:p>All patients had oligomenorrhea or amenorrhea. None had hyperandrogenism. Low-normal serum estradiol (E2) and testosterone levels contrasted with chronically increased serum P and 17-OHP levels, which further increased after adrenocorticotrophic hormone (ACTH) administration. Despite excessive P, 17OH-P and 21-deoxycortisol rise after ACTH stimulation suggesting non-classic 21OH-D, CYP21A2 sequencing did not support this hypothesis. Basal serum cortisol levels were low to normal, with inadequate response to ACTH in some women, suggesting partial adrenal insufficiency. All patients harbored rare biallelic POR mutations classified as pathogenic or likely pathogenic according to the American College of Medical Genetics and Genomics standards. Pelvic imaging revealed bilateral ovarian macrocysts in all women. IVF was performed for two women after retrieval of a normal oocyte number despite very low E2 levels during ovarian stimulation. Frozen ET under glucocorticoid suppression therapy led to successful pregnancies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>LIMITATIONS, REASONS FOR CAUTION<\/jats:title>\n                    <jats:p>The number of patients described here is limited and these data need to be confirmed on a larger number of women with non-classic PORD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>WIDER IMPLICATIONS OF THE FINDINGS<\/jats:title>\n                    <jats:p>The diagnosis of PORD must be considered in infertile women with chronically elevated P and 17OH-P levels and ovarian macrocysts. Differentiation of this entity from non-classic 21OH-D is important, as the multiple enzyme deficiency requires a specific management. Successful fertility induction is possible by IVF, providing that P levels be sufficiently suppressed by glucocorticoid therapy prior to implantation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>STUDY FUNDING\/COMPETING INTEREST(S)<\/jats:title>\n                    <jats:p>No specific funding was used for this study. There are no potential conflicts of interest.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>TRIAL REGISTRATION NUMBER<\/jats:title>\n                    <jats:p>N\/A<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/humrep\/deaa020","type":"journal-article","created":{"date-parts":[[2020,3,13]],"date-time":"2020-03-13T16:24:39Z","timestamp":1584116679000},"page":"939-949","source":"Crossref","is-referenced-by-count":33,"title":["Non-classic cytochrome P450 oxidoreductase deficiency strongly linked with menstrual cycle disorders and female infertility as primary manifestations"],"prefix":"10.1093","volume":"35","author":[{"given":"Georgios E","family":"Papadakis","sequence":"first","affiliation":[{"name":"Service of Endocrinology, Diabetes and Metabolism, Lausanne University Hospital, CH-1011 Lausanne, Switzerland"},{"name":"Department of Reproductive Endocrinology, Assistance Publique-H\u00f4pitaux de Paris, H\u00f4pital Bic\u00eatre, F-94275 Le Kremlin-Bic\u00eatre, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agathe","family":"Dumont","sequence":"first","affiliation":[{"name":"Department of Reproductive Medicine, Universit\u00e9 de Lille, Centre Hospitalier Universitaire (CHU) Lille, F-59000 Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome","family":"Bouligand","sequence":"first","affiliation":[{"name":"Service de G\u00e9n\u00e9tique Mol\u00e9culaire, Pharmacog\u00e9n\u00e9tique et Hormonologie, Assistance Publique-H\u00f4pitaux de Paris, H\u00f4pital Bic\u00eatre, Kremlin-Bic\u00eatre F-94275 France"},{"name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale (INSERM) Unit\u00e9 Mixte de Recherche-U1185, Fac Med Paris Saclay, Universit\u00e9 Paris-Saclay, F-94276 Le Kremlin-Bic\u00eatre, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Chasseloup","sequence":"first","affiliation":[{"name":"Service de G\u00e9n\u00e9tique Mol\u00e9culaire, Pharmacog\u00e9n\u00e9tique et Hormonologie, Assistance Publique-H\u00f4pitaux de Paris, H\u00f4pital Bic\u00eatre, Kremlin-Bic\u00eatre F-94275 France"},{"name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale (INSERM) Unit\u00e9 Mixte de Recherche-U1185, Fac Med Paris Saclay, Universit\u00e9 Paris-Saclay, F-94276 Le Kremlin-Bic\u00eatre, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Raggi","sequence":"first","affiliation":[{"name":"Fertisuisse, CH-4600 Olten, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Catteau-Jonard","sequence":"first","affiliation":[{"name":"Department of Reproductive Medicine, Universit\u00e9 de Lille, Centre Hospitalier Universitaire (CHU) Lille, F-59000 Lille, France"},{"name":"University of Lille, Laboratory of Development and Plasticity of the Neuroendocrine Brain, INSERM U1172, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odile","family":"Boute-Benejean","sequence":"first","affiliation":[{"name":"Department of Clinical Genetics, Universit\u00e9 de Lille, CHU Lille, F-59000 Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelly","family":"Pitteloud","sequence":"first","affiliation":[{"name":"Service of Endocrinology, Diabetes and Metabolism, Lausanne University Hospital, CH-1011 Lausanne, Switzerland"},{"name":"Faculty of Biology and Medicine, University of Lausanne, CH-1011 Lausanne, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Young","sequence":"first","affiliation":[{"name":"Department of Reproductive Endocrinology, Assistance Publique-H\u00f4pitaux de Paris, H\u00f4pital Bic\u00eatre, F-94275 Le Kremlin-Bic\u00eatre, France"},{"name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale (INSERM) Unit\u00e9 Mixte de Recherche-U1185, Fac Med Paris Saclay, Universit\u00e9 Paris-Saclay, F-94276 Le Kremlin-Bic\u00eatre, France"},{"name":"Universit\u00e9 Paris-Saclay, F-91405 Orsay Cedex, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Dewailly","sequence":"first","affiliation":[{"name":"Department of Reproductive Medicine, Universit\u00e9 de Lille, Centre Hospitalier Universitaire (CHU) Lille, F-59000 Lille, France"},{"name":"University of Lille, Laboratory of Development and Plasticity of the Neuroendocrine Brain, INSERM U1172, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,4,3]]},"reference":[{"key":"2020043013360679400_ref1","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/S0140-6736(04)16503-3","article-title":"Congenital adrenal hyperplasia caused by mutant P450 oxidoreductase and human androgen synthesis: analytical study","volume":"363","author":"Arlt","year":"2004","journal-title":"Lancet"},{"key":"2020043013360679400_ref2","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13048-017-0312-9","article-title":"Cytochrome P450 oxidoreductase deficiency caused by R457H mutation in POR gene in Chinese: case report and literature review","volume":"10","author":"Bai","year":"2017","journal-title":"J Ovarian Res"},{"key":"2020043013360679400_ref3","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1210\/jc.2008-1582","article-title":"Clinical and molecular characterization of a cohort of 161 unrelated women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency and 330 family members","volume":"94","author":"Bidet","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2020043013360679400_ref4","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1093\/humrep\/deq125","article-title":"Circulating progesterone levels and ongoing pregnancy rates in controlled ovarian stimulation cycles for in vitro fertilization: analysis of over 4000 cycles","volume":"25","author":"Bosch","year":"2010","journal-title":"Hum Reprod"},{"key":"2020043013360679400_ref5","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/cen.12646","article-title":"Secondary amenorrhoea associated with high serum 17-hydroxyprogesterone levels revealing a heterozygous CYP21A2 mutation in a woman with Addison disease","volume":"82","author":"Boscolo","year":"2015","journal-title":"Clin Endocrinol"},{"key":"2020043013360679400_ref6","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1210\/jc.2016-3799","article-title":"Anti-mullerian hormone and ovarian morphology in women with isolated hypogonadotropic hypogonadism\/Kallmann syndrome: effects of recombinant human FSH","volume":"102","author":"Bry-Gauillard","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"2020043013360679400_ref7","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.fertnstert.2007.11.064","article-title":"Primary amenorrhea revealing an occult progesterone-secreting ovarian tumor","volume":"90","author":"Bry-Gauillard","year":"2008","journal-title":"Fertil Steril"},{"key":"2020043013360679400_ref8","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jsbmb.2016.04.003","article-title":"P450 oxidoreductase deficiency: analysis of mutations and polymorphisms","volume":"165","author":"Burkhard","year":"2017","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2020043013360679400_ref9","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/humupd\/dmt061","article-title":"Definition and significance of polycystic ovarian morphology: a task force report from the androgen excess and polycystic ovary syndrome society","volume":"20","author":"Dewailly","year":"2014","journal-title":"Hum Reprod Update"},{"key":"2020043013360679400_ref10","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/humupd\/dmw027","article-title":"Interactions between androgens, FSH, anti-mullerian hormone and estradiol during folliculogenesis in the human normal and polycystic ovary","volume":"22","author":"Dewailly","year":"2016","journal-title":"Hum Reprod Update"},{"key":"2020043013360679400_ref11","doi-asserted-by":"crossref","first-page":"194","DOI":"10.7326\/0003-4819-139-3-200308050-00009","article-title":"Diagnosis of adrenal insufficiency","volume":"139","author":"Dorin","year":"2003","journal-title":"Ann Intern Med"},{"key":"2020043013360679400_ref12","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/ng1300","article-title":"Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley\u2013Bixler syndrome","volume":"36","author":"Fluck","year":"2004","journal-title":"Nat Genet"},{"key":"2020043013360679400_ref13","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1210\/jc.2004-0810","article-title":"Cytochrome P450 oxidoreductase gene mutations and Antley\u2013Bixler syndrome with abnormal genitalia and\/or impaired steroidogenesis: molecular and clinical studies in 10 patients","volume":"90","author":"Fukami","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2020043013360679400_ref14","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ymgme.2010.03.023","article-title":"Anorectal and urinary anomalies and aberrant retinoic acid metabolism in cytochrome P450 oxidoreductase deficiency","volume":"100","author":"Fukami","year":"2010","journal-title":"Mol Genet Metab"},{"key":"2020043013360679400_ref15","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1210\/jc.2008-2816","article-title":"Cytochrome P450 oxidoreductase deficiency: identification and characterization of biallelic mutations and genotype-phenotype correlations in 35 Japanese patients","volume":"94","author":"Fukami","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2020043013360679400_ref16","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/ped.12518","article-title":"Cytochrome P450 oxidoreductase deficiency: rare congenital disorder leading to skeletal malformations and steroidogenic defects","volume":"56","author":"Fukami","year":"2014","journal-title":"Pediatr Int"},{"key":"2020043013360679400_ref17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/humrep\/15.suppl_5.3","article-title":"Human oocyte maturation in vitro is stimulated by meiosis-activating sterol","volume":"15","author":"Grondahl","year":"2000","journal-title":"Hum Reprod"},{"key":"2020043013360679400_ref18","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1365-2265.1995.tb02034.x","article-title":"Menstrual disturbance and hypersecretion of progesterone in women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"43","author":"Holmes-Walker","year":"1995","journal-title":"Clin Endocrinol"},{"key":"2020043013360679400_ref19","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1086\/429417","article-title":"Diversity and function of mutations in p450 oxidoreductase in patients with Antley\u2013Bixler syndrome and disordered steroidogenesis","volume":"76","author":"Huang","year":"2005","journal-title":"Am J Hum Genet"},{"key":"2020043013360679400_ref20","doi-asserted-by":"crossref","first-page":"E453","DOI":"10.1210\/jc.2010-1607","article-title":"Pubertal presentation in seven patients with congenital adrenal hyperplasia due to P450 oxidoreductase deficiency","volume":"96","author":"Idkowiak","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"2020043013360679400_ref21","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1210\/clinem\/dgz005","article-title":"Cortisol and aldosterone responses to hypoglycemia and Na depletion in women with non-classic 21-hydroxylase deficiency","volume":"105","author":"Kamenicky","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"2020043013360679400_ref22","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/ajmg.10510","article-title":"Abnormal sterol metabolism in a patient with Antley\u2013Bixler syndrome and ambiguous genitalia","volume":"110","author":"Kelley","year":"2002","journal-title":"Am J Med Genet"},{"key":"2020043013360679400_ref23","doi-asserted-by":"crossref","first-page":"E257","DOI":"10.1210\/jc.2011-0640","article-title":"Genotype-phenotype analysis in congenital adrenal hyperplasia due to P450 oxidoreductase deficiency","volume":"97","author":"Krone","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2020043013360679400_ref24","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1530\/EJE-14-1084","article-title":"LC-MS\/MS based determination of basal- and ACTH-stimulated plasma concentrations of 11 steroid hormones: implications for detecting heterozygote CYP21A2 mutation carriers","volume":"173","author":"Kulle","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"2020043013360679400_ref25","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1056\/NEJM198605153142015","article-title":"Congenital adrenal hyperplasia","volume":"314","author":"Miller","year":"1986","journal-title":"N Engl J Med"},{"key":"2020043013360679400_ref26","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1210\/me.2007-0245","article-title":"Modulation of human CYP19A1 activity by mutant NADPH P450 oxidoreductase","volume":"21","author":"Pandey","year":"2007","journal-title":"Mol Endocrinol"},{"key":"2020043013360679400_ref27","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa076","article-title":"Molecular basis of aromatase deficiency in a 46, XX patient with mutation of arginine 550 to tryptophan in POR: expanding the endocrine phenotype in PORD","volume-title":"J Clin Endocrinol Metab","author":"Parween","year":"2020"},{"key":"2020043013360679400_ref28","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1056\/NEJM198511073131903","article-title":"Male pseudohermaphroditism due to multiple defects in steroid-biosynthetic microsomal mixed-function oxidases. A new variant of congenital adrenal hyperplasia","volume":"313","author":"Peterson","year":"1985","journal-title":"N Engl J Med"},{"key":"2020043013360679400_ref29","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.fertnstert.2013.11.002","article-title":"Fertility in patients with congenital adrenal hyperplasia","volume":"101","author":"Reichman","year":"2014","journal-title":"Fertil Steril"},{"key":"2020043013360679400_ref30","doi-asserted-by":"crossref","first-page":"E528","DOI":"10.1210\/jc.2012-3449","article-title":"Prenatal diagnosis of congenital adrenal hyperplasia caused by P450 oxidoreductase deficiency","volume":"98","author":"Reisch","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"2020043013360679400_ref31","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"2020043013360679400_ref32","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.gyobfe.2014.04.005","article-title":"Steroid 21-hydroxylase deficiencies and female infertility: pathophysiology and management","volume":"42","author":"Robin","year":"2014","journal-title":"Gynecol Obstet Fertil"},{"key":"2020043013360679400_ref33","doi-asserted-by":"crossref","first-page":"4992","DOI":"10.1210\/jc.2009-1460","article-title":"Clinical, genetic, and enzymatic characterization of P450 oxidoreductase deficiency in four patients","volume":"94","author":"Sahakitrungruang","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2020043013360679400_ref34","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1530\/EJE-14-0670","article-title":"Ovarian macrocysts and gonadotrope-ovarian axis disruption in premenopausal women receiving mitotane for adrenocortical carcinoma or Cushing\u2019s disease","volume":"172","author":"Salenave","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"2020043013360679400_ref35","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1128\/MCB.01638-08","article-title":"Cholesterol metabolism: the main pathway acting downstream of cytochrome P450 oxidoreductase in skeletal development of the limb","volume":"29","author":"Schmidt","year":"2009","journal-title":"Mol Cell Biol"},{"key":"2020043013360679400_ref36","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1159\/000114857","article-title":"Genetic and clinical features of p450 oxidoreductase deficiency","volume":"69","author":"Scott","year":"2008","journal-title":"Horm Res"},{"key":"2020043013360679400_ref37","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1080\/09513590.2017.1393663","article-title":"In vitro fertilization-frozen embryo transfer in a patient with cytochrome P450 oxidoreductase deficiency: a case report","volume":"34","author":"Song","year":"2018","journal-title":"Gynecol Endocrinol"},{"key":"2020043013360679400_ref38","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1002\/ajmg.a.31385","article-title":"Linking Antley\u2013Bixler syndrome and congenital adrenal hyperplasia: a novel case of P450 oxidoreductase deficiency","volume":"140A","author":"Williamson","year":"2006","journal-title":"Am J Med Genet A"},{"key":"2020043013360679400_ref39","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/MED.0b013e32835a1a2e","article-title":"Management of CAH during pregnancy: optimizing outcomes","volume":"19","author":"Witchel","year":"2012","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"2020043013360679400_ref40","doi-asserted-by":"crossref","first-page":"13486","DOI":"10.1073\/pnas.1106632108","article-title":"Structural basis for human NADPH-cytochrome P450 oxidoreductase deficiency","volume":"108","author":"Xia","year":"2011","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/humrep\/article-pdf\/35\/4\/939\/33149666\/deaa020.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/humrep\/article-pdf\/35\/4\/939\/33149666\/deaa020.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T14:24:16Z","timestamp":1588256656000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/humrep\/article\/35\/4\/939\/5815139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":40,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,4,3]]},"published-print":{"date-parts":[[2020,4,28]]}},"URL":"https:\/\/doi.org\/10.1093\/humrep\/deaa020","relation":{},"ISSN":["0268-1161","1460-2350"],"issn-type":[{"value":"0268-1161","type":"print"},{"value":"1460-2350","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,4]]},"published":{"date-parts":[[2020,4]]}}}